Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
PULMOCIDE LIMITED
2821
PULMOCIDE LIMITED
Health Care
Technology
Biotechnology
Medical
Diagnostics
Health Diagnostics
Pulmocide is focused on the development of inhaled medicines for the treatmentof viral and fungal infections of the respiratory tract.
Suggest edits
Type
B2c
Founded
2013
Raised
$58M
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
DeepMind
HSBC
Revolut
Cambridge Analytica
Volkswagen
Ubuntu
Companies in the same industry
Imutex
Prometic
NanoCellect Biomedical
Congenica
CCG
Orchard Therapeutics
T2 Biosystems
myTomorrows
Oxford Immunotec
GrandOmics
Alexa global traffic share
Overview
Funding
2
Add info
Add round
20 Mar
2017
$30,000,000
Venture capital (Series B)
SV Life Sciences
,
F-Prime Capital Partners
,
Johnson & Johnson
,
+2
British biotech Pulmocide raises £24m in bid to find treatment for deadly lung diseases
The Telegraph
+1
26 Nov
2013
$27,541,217
Venture capital (Series A)
